• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMU 4.00% 4.8¢

IMUGENE LIMITED - Announcements

Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing... Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs. More

Announcements


Filters [Clear]
  • Price Sensitive: Yes
IMU Trading HaltPRICE SENSITIVE05/06/18 download Created with Sketch. 443.43KB
IMU Appendix 4C - quarterlyPRICE SENSITIVE26/04/18 download Created with Sketch. 658.65KB
IMU Leslie Chong Appointed as Managing DirectorPRICE SENSITIVE28/03/18 download Created with Sketch. 223.16KB
IMU Half Yearly Report and AccountsPRICE SENSITIVE27/02/18 download Created with Sketch. 273.35KB
IMU Arginine Modulator Active in Cancer ModelsPRICE SENSITIVE19/02/18 download Created with Sketch. 242.78KB
IMU Novel Anti-PD-1 Mimotope Vaccine Ready for DevelopmentPRICE SENSITIVE12/02/18 download Created with Sketch. 167.45KB
IMU IMU Meets Investigator for Gastric Cancer Clinical TrialPRICE SENSITIVE09/02/18 download Created with Sketch. 45.28KB
IMU Cancer vaccine shows early promise in clinical trialPRICE SENSITIVE07/02/18 download Created with Sketch. 238.61KB
IMU Business Update - December Quarter Appendix 4CPRICE SENSITIVE29/01/18 download Created with Sketch. 986.49KB
IMU Rights Issue Results & Shortfall NotificationPRICE SENSITIVE19/12/17 download Created with Sketch. 37.68KB
IMU ProspectusPRICE SENSITIVE23/11/17 download Created with Sketch. 946.63KB
IMU IMUGENE RAISES $8.7 MILLIONPRICE SENSITIVE23/11/17 download Created with Sketch. 72.07KB
IMU Trading HaltPRICE SENSITIVE21/11/17 download Created with Sketch. 264.26KB
IMU Appendix 4C - Quarterly and Business UpdatePRICE SENSITIVE27/10/17 download Created with Sketch. 990.52KB
IMU Response to ASX Price QueryPRICE SENSITIVE17/10/17 download Created with Sketch. 609.6KB
IMU IMU Receives $1.1m R&D Tax RefundPRICE SENSITIVE11/10/17 download Created with Sketch. 296.02KB
IMU First Patient Dosing Commences of HER-VaxxPRICE SENSITIVE31/08/17 download Created with Sketch. 53.78KB
IMU Appendix 4E and Annual ReportPRICE SENSITIVE31/08/17 download Created with Sketch. 642.26KB
IMU Appendix 4C - quarterlyPRICE SENSITIVE31/07/17 download Created with Sketch. 984.1KB
IMU Imugene granted Canadian patent for Her-Vaxx cancer vaccinePRICE SENSITIVE21/07/17 download Created with Sketch. 42.21KB
IMU Appendix 4C - quarterly and Commentry Q3PRICE SENSITIVE28/04/17 download Created with Sketch. 856.23KB
IMU IMU Raises $3.0m from Options PlanPRICE SENSITIVE06/04/17 download Created with Sketch. 33.34KB
IMU $1.35 million Options UnderwrittenPRICE SENSITIVE30/03/17 download Created with Sketch. 66.21KB
IMU Half Year Report and AccountsPRICE SENSITIVE28/02/17 download Created with Sketch. 219.56KB
IMU Intellectual Property Strengthened Around Lead Clinical DrugPRICE SENSITIVE27/02/17 download Created with Sketch. 247.31KB
IMU BMC Cancer journal publishes encouraging HER-Vaxx researchPRICE SENSITIVE13/02/17 download Created with Sketch. 243.06KB
IMU Appendix 4C - quarterlyPRICE SENSITIVE27/01/17 download Created with Sketch. 295.18KB
IMU Imugene progresses mimotope platformPRICE SENSITIVE19/12/16 download Created with Sketch. 239.63KB
IMU Response to ASX Aware QueryPRICE SENSITIVE16/12/16 download Created with Sketch. 202.23KB
IMU Response to ASX Price QueryPRICE SENSITIVE13/12/16 download Created with Sketch. 412.71KB
IMU Acquisition of immuno-oncology technologyPRICE SENSITIVE13/12/16 download Created with Sketch. 83.3KB
IMU Response to ASX Price QueryPRICE SENSITIVE25/11/16 download Created with Sketch. 172.93KB
IMU Leslie Chong Appointed Chief Executive OfficerPRICE SENSITIVE21/11/16 download Created with Sketch. 174.4KB
IMU Imugene Commences HER-Vaxx Phase 1b/2 Gastric Cancer StudyPRICE SENSITIVE07/11/16 download Created with Sketch. 179.34KB
IMU Appendix 4C - quarterly-IMU.AX PRICE SENSITIVE27/10/16 download Created with Sketch. 296.35KB
IMU Imugene Share Placement raises $3.2 million-IMU.AX PRICE SENSITIVE21/10/16 download Created with Sketch. 170.52KB
IMU Trading Halt-IMU.AX PRICE SENSITIVE19/10/16 download Created with Sketch. 268.86KB
IMU Imugene receives $1.3m R&D Tax Refund-IMU.AX PRICE SENSITIVE22/09/16 download Created with Sketch. 152.62KB
IMU Imugene successfully completes preclinical animal studies-IMU.AX PRICE SENSITIVE20/09/16 download Created with Sketch. 56.94KB
IMU Preliminary Final Report-IMU.AX PRICE SENSITIVE30/08/16 download Created with Sketch. 123.14KB
IMU Imugene Final Cancer Vaccine Doses Delivered to GMP Depot-IMU.AX PRICE SENSITIVE30/08/16 download Created with Sketch. 61.47KB
IMU Imugene Receives Approval to Start Gastric Cancer Study-IMU.AX PRICE SENSITIVE22/08/16 download Created with Sketch. 173.4KB
IMU Imugene Receives Institutional Review Board approval-IMU.AX PRICE SENSITIVE11/08/16 download Created with Sketch. 44.54KB
IMU Appendix 4C - quarterly-IMU.AX PRICE SENSITIVE29/07/16 download Created with Sketch. 392.39KB
IMU Imugene Receives Institutional Review Board Approval-IMU.AX PRICE SENSITIVE11/07/16 download Created with Sketch. 268.17KB
IMU Appendix 4C - quarterly-IMU.AX PRICE SENSITIVE29/04/16 download Created with Sketch. 689.56KB
IMU Regulatory package submission for Her-Vaxx in Hong Kong-IMU.AX PRICE SENSITIVE21/04/16 download Created with Sketch. 140.36KB
IMU Manufacturing UpdatePRICE SENSITIVE07/03/16 download Created with Sketch. 50.79KB
IMU Half Yearly Report and AccountsPRICE SENSITIVE29/02/16 download Created with Sketch. 695.7KB
IMU Appendix 4C - quarterlyPRICE SENSITIVE27/01/16 download Created with Sketch. 153.95KB
IMU Partnership to Develop Mimotope Immuno-Oncology PlatformPRICE SENSITIVE20/01/16 download Created with Sketch. 56.12KB
IMU Imugene key HER-Vaxx patent granted in EuropePRICE SENSITIVE18/12/15 download Created with Sketch. 45.22KB
IMU Novotech appointed Contract Research OrganisationPRICE SENSITIVE14/12/15 download Created with Sketch. 48.37KB
IMU Appendix 4C - quarterlyPRICE SENSITIVE28/10/15 download Created with Sketch. 143.97KB
IMU Imugene Receives $755k R&D Tax RefundPRICE SENSITIVE28/10/15 download Created with Sketch. 116.37KB
IMU Prospectus for Placement & Loyalty OptionsPRICE SENSITIVE23/10/15 download Created with Sketch. 2.45MB
IMU Imugene announces bonus options issuePRICE SENSITIVE13/10/15 download Created with Sketch. 40.75KB
IMU Imugene Announces Successful Capital RaisingPRICE SENSITIVE08/09/15 download Created with Sketch. 71.52KB
IMU Trading HaltPRICE SENSITIVE07/09/15 download Created with Sketch. 326.63KB
IMU Appendix 4E and Annual Report 2015PRICE SENSITIVE31/08/15 download Created with Sketch. 1.57MB
IMU Appendix 4C - quarterlyPRICE SENSITIVE30/07/15 download Created with Sketch. 152.1KB
IMU CRO Appointed to Conduct Phase 1b/2 Gastric Cancer TrialPRICE SENSITIVE01/07/15 download Created with Sketch. 106.09KB
IMU HER-Vaxx superior to Herceptin in tumour modelPRICE SENSITIVE22/05/15 download Created with Sketch. 570.55KB
IMU Appendix 4C - quarterlyPRICE SENSITIVE29/04/15 download Created with Sketch. 152.22KB
IMU Imugene Files New HER-Vaxx PatentPRICE SENSITIVE21/04/15 download Created with Sketch. 62.06KB
IMU HER-Vaxx Re-Formulation Increases Efficacy Ten-FoldPRICE SENSITIVE20/04/15 download Created with Sketch. 75.2KB
IMU Appendix 4D - Half Yearly Report and AccountsPRICE SENSITIVE27/02/15 download Created with Sketch. 809.86KB
IMU Response to Price QueryPRICE SENSITIVE20/02/15 download Created with Sketch. 216.08KB
IMU Imugene Receives $230K Research and Development Tax RefundPRICE SENSITIVE18/02/15 download Created with Sketch. 57.21KB
IMU Appointment of Charles Walker as Managing DirectorPRICE SENSITIVE02/02/15 download Created with Sketch. 51.96KB
IMU Appendix 4C - quarterlyPRICE SENSITIVE28/01/15 download Created with Sketch. 152.73KB
IMU New milestones in preparation for HER-Vaxx clinical trialPRICE SENSITIVE30/12/14 download Created with Sketch. 68.18KB
IMU Further placement & close of SPP raising over $3.5m in totalPRICE SENSITIVE09/12/14 download Created with Sketch. 65.49KB
IMU HER-Vaxx peptides demonstrate high level of activityPRICE SENSITIVE01/12/14 download Created with Sketch. 73.12KB
IMU Imugene to divest Linguet drug delivery technologyPRICE SENSITIVE28/11/14 download Created with Sketch. 64.48KB
IMU Capital raising for clinical development of HER-VaxxPRICE SENSITIVE05/11/14 download Created with Sketch. 79.82KB
IMU Trading HaltPRICE SENSITIVE03/11/14 download Created with Sketch. 163.68KB
IMU Appendix 4C - quarterlyPRICE SENSITIVE31/10/14 download Created with Sketch. 178.02KB
IMU Imugene HER-Vaxx patent granted in USPRICE SENSITIVE08/10/14 download Created with Sketch. 104.95KB
IMU Swiss Drug Manufacturer to Speed Her-Vaxx DevelopmentPRICE SENSITIVE15/09/14 download Created with Sketch. 94.26KB
IMU Research Agreement with Medical University of ViennaPRICE SENSITIVE08/09/14 download Created with Sketch. 58.5KB
IMU Appendix 4E and Annual Financial ReportPRICE SENSITIVE28/08/14 download Created with Sketch. 987.16KB
IMU Charles Walker appointed Imugene CEOPRICE SENSITIVE26/08/14 download Created with Sketch. 124.5KB
IMU HER-Vaxx patent application receives US Notice of AllowancePRICE SENSITIVE29/07/14 download Created with Sketch. 106.17KB
IMU Appendix 4C - quarterlyPRICE SENSITIVE25/07/14 download Created with Sketch. 171.12KB
IMU Mymetics Engaged to Manufacture HER-VaxxPRICE SENSITIVE16/07/14 download Created with Sketch. 198.68KB
IMUImugene Commences Manufacture of its Gastric Cancer VaccinePRICE SENSITIVE27/05/14 download Created with Sketch. 194.51KB
IMUAppendix 4C - quarterlyPRICE SENSITIVE23/04/14 download Created with Sketch. 152.97KB
IMUImugene Allowed Israel Patent for Cancer VaccinePRICE SENSITIVE24/03/14 download Created with Sketch. 141.35KB
IMUIMU Commences FDA IND Process for Gastric Cancer vaccinePRICE SENSITIVE17/03/14 download Created with Sketch. 148.33KB
IMUHalf Yearly Report and AccountsPRICE SENSITIVE27/02/14 download Created with Sketch. 715.65KB
IMUAppendix 4C - quarterlyPRICE SENSITIVE29/01/14 download Created with Sketch. 159.44KB
IMUImugene Secures Important Intellectual PropertyPRICE SENSITIVE19/12/13 download Created with Sketch. 120.04KB
IMUAppendix 4C - quarterlyPRICE SENSITIVE24/10/13 download Created with Sketch. 162.22KB
IMUCapital Raising CompletePRICE SENSITIVE23/10/13 download Created with Sketch. 88.95KB
IMUImugene to acquire Biolife Science Qld LimitedPRICE SENSITIVE23/10/13 download Created with Sketch. 650.74KB
IMUTrading HaltPRICE SENSITIVE21/10/13 download Created with Sketch. 235.35KB
IMUEuropean patent for novel drug delivery technologyPRICE SENSITIVE27/09/13 download Created with Sketch. 180.2KB
CGP +Shareholder UpdatePRICE SENSITIVE19/09/13 download Created with Sketch. 263.66KB
IMUImugene discontinues ibuprofen developmentPRICE SENSITIVE18/09/13 download Created with Sketch. 103.49KB
IMU Trading Halt
05/06/18PRICE SENSITIVE download Created with Sketch. 443.43KB
IMU Appendix 4C - quarterly
26/04/18PRICE SENSITIVE download Created with Sketch. 658.65KB
IMU Leslie Chong Appointed as Managing Director
28/03/18PRICE SENSITIVE download Created with Sketch. 223.16KB
IMU Half Yearly Report and Accounts
27/02/18PRICE SENSITIVE download Created with Sketch. 273.35KB
IMU Arginine Modulator Active in Cancer Models
19/02/18PRICE SENSITIVE download Created with Sketch. 242.78KB
IMU Novel Anti-PD-1 Mimotope Vaccine Ready for Development
12/02/18PRICE SENSITIVE download Created with Sketch. 167.45KB
IMU IMU Meets Investigator for Gastric Cancer Clinical Trial
09/02/18PRICE SENSITIVE download Created with Sketch. 45.28KB
IMU Cancer vaccine shows early promise in clinical trial
07/02/18PRICE SENSITIVE download Created with Sketch. 238.61KB
IMU Business Update - December Quarter Appendix 4C
29/01/18PRICE SENSITIVE download Created with Sketch. 986.49KB
IMU Rights Issue Results & Shortfall Notification
19/12/17PRICE SENSITIVE download Created with Sketch. 37.68KB
IMU Prospectus
23/11/17PRICE SENSITIVE download Created with Sketch. 946.63KB
IMU IMUGENE RAISES $8.7 MILLION
23/11/17PRICE SENSITIVE download Created with Sketch. 72.07KB
IMU Trading Halt
21/11/17PRICE SENSITIVE download Created with Sketch. 264.26KB
IMU Appendix 4C - Quarterly and Business Update
27/10/17PRICE SENSITIVE download Created with Sketch. 990.52KB
IMU Response to ASX Price Query
17/10/17PRICE SENSITIVE download Created with Sketch. 609.6KB
IMU IMU Receives $1.1m R&D Tax Refund
11/10/17PRICE SENSITIVE download Created with Sketch. 296.02KB
IMU First Patient Dosing Commences of HER-Vaxx
31/08/17PRICE SENSITIVE download Created with Sketch. 53.78KB
IMU Appendix 4E and Annual Report
31/08/17PRICE SENSITIVE download Created with Sketch. 642.26KB
IMU Appendix 4C - quarterly
31/07/17PRICE SENSITIVE download Created with Sketch. 984.1KB
IMU Imugene granted Canadian patent for Her-Vaxx cancer vaccine
21/07/17PRICE SENSITIVE download Created with Sketch. 42.21KB
IMU Appendix 4C - quarterly and Commentry Q3
28/04/17PRICE SENSITIVE download Created with Sketch. 856.23KB
IMU IMU Raises $3.0m from Options Plan
06/04/17PRICE SENSITIVE download Created with Sketch. 33.34KB
IMU $1.35 million Options Underwritten
30/03/17PRICE SENSITIVE download Created with Sketch. 66.21KB
IMU Half Year Report and Accounts
28/02/17PRICE SENSITIVE download Created with Sketch. 219.56KB
IMU Intellectual Property Strengthened Around Lead Clinical Drug
27/02/17PRICE SENSITIVE download Created with Sketch. 247.31KB
IMU BMC Cancer journal publishes encouraging HER-Vaxx research
13/02/17PRICE SENSITIVE download Created with Sketch. 243.06KB
IMU Appendix 4C - quarterly
27/01/17PRICE SENSITIVE download Created with Sketch. 295.18KB
IMU Imugene progresses mimotope platform
19/12/16PRICE SENSITIVE download Created with Sketch. 239.63KB
IMU Response to ASX Aware Query
16/12/16PRICE SENSITIVE download Created with Sketch. 202.23KB
IMU Response to ASX Price Query
13/12/16PRICE SENSITIVE download Created with Sketch. 412.71KB
IMU Acquisition of immuno-oncology technology
13/12/16PRICE SENSITIVE download Created with Sketch. 83.3KB
IMU Response to ASX Price Query
25/11/16PRICE SENSITIVE download Created with Sketch. 172.93KB
IMU Leslie Chong Appointed Chief Executive Officer
21/11/16PRICE SENSITIVE download Created with Sketch. 174.4KB
IMU Imugene Commences HER-Vaxx Phase 1b/2 Gastric Cancer Study
07/11/16PRICE SENSITIVE download Created with Sketch. 179.34KB
IMU Appendix 4C - quarterly-IMU.AX
27/10/16PRICE SENSITIVE download Created with Sketch. 296.35KB
IMU Imugene Share Placement raises $3.2 million-IMU.AX
21/10/16PRICE SENSITIVE download Created with Sketch. 170.52KB
IMU Trading Halt-IMU.AX
19/10/16PRICE SENSITIVE download Created with Sketch. 268.86KB
IMU Imugene receives $1.3m R&D Tax Refund-IMU.AX
22/09/16PRICE SENSITIVE download Created with Sketch. 152.62KB
IMU Imugene successfully completes preclinical animal studies-IMU.AX
20/09/16PRICE SENSITIVE download Created with Sketch. 56.94KB
IMU Preliminary Final Report-IMU.AX
30/08/16PRICE SENSITIVE download Created with Sketch. 123.14KB
IMU Imugene Final Cancer Vaccine Doses Delivered to GMP Depot-IMU.AX
30/08/16PRICE SENSITIVE download Created with Sketch. 61.47KB
IMU Imugene Receives Approval to Start Gastric Cancer Study-IMU.AX
22/08/16PRICE SENSITIVE download Created with Sketch. 173.4KB
IMU Imugene Receives Institutional Review Board approval-IMU.AX
11/08/16PRICE SENSITIVE download Created with Sketch. 44.54KB
IMU Appendix 4C - quarterly-IMU.AX
29/07/16PRICE SENSITIVE download Created with Sketch. 392.39KB
IMU Imugene Receives Institutional Review Board Approval-IMU.AX
11/07/16PRICE SENSITIVE download Created with Sketch. 268.17KB
IMU Appendix 4C - quarterly-IMU.AX
29/04/16PRICE SENSITIVE download Created with Sketch. 689.56KB
IMU Regulatory package submission for Her-Vaxx in Hong Kong-IMU.AX
21/04/16PRICE SENSITIVE download Created with Sketch. 140.36KB
IMU Manufacturing Update
07/03/16PRICE SENSITIVE download Created with Sketch. 50.79KB
IMU Half Yearly Report and Accounts
29/02/16PRICE SENSITIVE download Created with Sketch. 695.7KB
IMU Appendix 4C - quarterly
27/01/16PRICE SENSITIVE download Created with Sketch. 153.95KB
IMU Partnership to Develop Mimotope Immuno-Oncology Platform
20/01/16PRICE SENSITIVE download Created with Sketch. 56.12KB
IMU Imugene key HER-Vaxx patent granted in Europe
18/12/15PRICE SENSITIVE download Created with Sketch. 45.22KB
IMU Novotech appointed Contract Research Organisation
14/12/15PRICE SENSITIVE download Created with Sketch. 48.37KB
IMU Appendix 4C - quarterly
28/10/15PRICE SENSITIVE download Created with Sketch. 143.97KB
IMU Imugene Receives $755k R&D Tax Refund
28/10/15PRICE SENSITIVE download Created with Sketch. 116.37KB
IMU Prospectus for Placement & Loyalty Options
23/10/15PRICE SENSITIVE download Created with Sketch. 2.45MB
IMU Imugene announces bonus options issue
13/10/15PRICE SENSITIVE download Created with Sketch. 40.75KB
IMU Imugene Announces Successful Capital Raising
08/09/15PRICE SENSITIVE download Created with Sketch. 71.52KB
IMU Trading Halt
07/09/15PRICE SENSITIVE download Created with Sketch. 326.63KB
IMU Appendix 4E and Annual Report 2015
31/08/15PRICE SENSITIVE download Created with Sketch. 1.57MB
IMU Appendix 4C - quarterly
30/07/15PRICE SENSITIVE download Created with Sketch. 152.1KB
IMU CRO Appointed to Conduct Phase 1b/2 Gastric Cancer Trial
01/07/15PRICE SENSITIVE download Created with Sketch. 106.09KB
IMU HER-Vaxx superior to Herceptin in tumour model
22/05/15PRICE SENSITIVE download Created with Sketch. 570.55KB
IMU Appendix 4C - quarterly
29/04/15PRICE SENSITIVE download Created with Sketch. 152.22KB
IMU Imugene Files New HER-Vaxx Patent
21/04/15PRICE SENSITIVE download Created with Sketch. 62.06KB
IMU HER-Vaxx Re-Formulation Increases Efficacy Ten-Fold
20/04/15PRICE SENSITIVE download Created with Sketch. 75.2KB
IMU Appendix 4D - Half Yearly Report and Accounts
27/02/15PRICE SENSITIVE download Created with Sketch. 809.86KB
IMU Response to Price Query
20/02/15PRICE SENSITIVE download Created with Sketch. 216.08KB
IMU Imugene Receives $230K Research and Development Tax Refund
18/02/15PRICE SENSITIVE download Created with Sketch. 57.21KB
IMU Appointment of Charles Walker as Managing Director
02/02/15PRICE SENSITIVE download Created with Sketch. 51.96KB
IMU Appendix 4C - quarterly
28/01/15PRICE SENSITIVE download Created with Sketch. 152.73KB
IMU New milestones in preparation for HER-Vaxx clinical trial
30/12/14PRICE SENSITIVE download Created with Sketch. 68.18KB
IMU Further placement & close of SPP raising over $3.5m in total
09/12/14PRICE SENSITIVE download Created with Sketch. 65.49KB
IMU HER-Vaxx peptides demonstrate high level of activity
01/12/14PRICE SENSITIVE download Created with Sketch. 73.12KB
IMU Imugene to divest Linguet drug delivery technology
28/11/14PRICE SENSITIVE download Created with Sketch. 64.48KB
IMU Capital raising for clinical development of HER-Vaxx
05/11/14PRICE SENSITIVE download Created with Sketch. 79.82KB
IMU Trading Halt
03/11/14PRICE SENSITIVE download Created with Sketch. 163.68KB
IMU Appendix 4C - quarterly
31/10/14PRICE SENSITIVE download Created with Sketch. 178.02KB
IMU Imugene HER-Vaxx patent granted in US
08/10/14PRICE SENSITIVE download Created with Sketch. 104.95KB
IMU Swiss Drug Manufacturer to Speed Her-Vaxx Development
15/09/14PRICE SENSITIVE download Created with Sketch. 94.26KB
IMU Research Agreement with Medical University of Vienna
08/09/14PRICE SENSITIVE download Created with Sketch. 58.5KB
IMU Appendix 4E and Annual Financial Report
28/08/14PRICE SENSITIVE download Created with Sketch. 987.16KB
IMU Charles Walker appointed Imugene CEO
26/08/14PRICE SENSITIVE download Created with Sketch. 124.5KB
IMU HER-Vaxx patent application receives US Notice of Allowance
29/07/14PRICE SENSITIVE download Created with Sketch. 106.17KB
IMU Appendix 4C - quarterly
25/07/14PRICE SENSITIVE download Created with Sketch. 171.12KB
IMU Mymetics Engaged to Manufacture HER-Vaxx
16/07/14PRICE SENSITIVE download Created with Sketch. 198.68KB
IMUImugene Commences Manufacture of its Gastric Cancer Vaccine
27/05/14PRICE SENSITIVE download Created with Sketch. 194.51KB
IMUAppendix 4C - quarterly
23/04/14PRICE SENSITIVE download Created with Sketch. 152.97KB
IMUImugene Allowed Israel Patent for Cancer Vaccine
24/03/14PRICE SENSITIVE download Created with Sketch. 141.35KB
IMUIMU Commences FDA IND Process for Gastric Cancer vaccine
17/03/14PRICE SENSITIVE download Created with Sketch. 148.33KB
IMUHalf Yearly Report and Accounts
27/02/14PRICE SENSITIVE download Created with Sketch. 715.65KB
IMUAppendix 4C - quarterly
29/01/14PRICE SENSITIVE download Created with Sketch. 159.44KB
IMUImugene Secures Important Intellectual Property
19/12/13PRICE SENSITIVE download Created with Sketch. 120.04KB
IMUAppendix 4C - quarterly
24/10/13PRICE SENSITIVE download Created with Sketch. 162.22KB
IMUCapital Raising Complete
23/10/13PRICE SENSITIVE download Created with Sketch. 88.95KB
IMUImugene to acquire Biolife Science Qld Limited
23/10/13PRICE SENSITIVE download Created with Sketch. 650.74KB
IMUTrading Halt
21/10/13PRICE SENSITIVE download Created with Sketch. 235.35KB
IMUEuropean patent for novel drug delivery technology
27/09/13PRICE SENSITIVE download Created with Sketch. 180.2KB
CGP +Shareholder Update
19/09/13PRICE SENSITIVE download Created with Sketch. 263.66KB
IMUImugene discontinues ibuprofen development
18/09/13PRICE SENSITIVE download Created with Sketch. 103.49KB
(20min delay)
Last
4.8¢
Change
-0.002(4.00%)
Mkt cap ! $356.9M
Open High Low Value Volume
5.0¢ 5.0¢ 4.7¢ $2.298M 47.86M

Buyers (Bids)

No. Vol. Price($)
5 1925982 4.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.9¢ 3452098 12
View Market Depth
Last trade - 16.10pm 27/09/2024 (20 minute delay) ?
Last
4.9¢
  Change
-0.002 ( 1.80 %)
Open High Low Volume
5.0¢ 5.0¢ 4.7¢ 31199735
Last updated 15.59pm 27/09/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.